Company | Recommendation | Buy (Rs) | Target (Rs) | Upside (%) | Time Horizon |
Asian Paints | Buy | 3156 | 3472 | 10% | 1 Month |
Infosys | Buy | 1643 | 1807 | 10% | 1 Month |
ITC | Buy | 336 | 371 | 10% | 1 Month |
LTIMindtree | Buy | 4975 | 5473 | 10% | 1 Month |
Maruti Suzuki | Buy | 8797 | 9677 | 10% | 1 Month |
Piramal Pharma | Buy | 142 | 156 | 10% | 1 Month |
Redington | Buy | 180 | 198 | 10% | 1 Month |
SBI | Buy | 617 | 679 | 10% | 1 Month |
Tata Chemicals | Buy | 1057 | 1163 | 10% | 1 Month |
Tata Steel | Buy | 116 | 128 | 10% | 1 Month |
Ultratech Cements | Buy | 7190 | 7909 | 10% | 1 Month |
Consider the prices as on 6th December 2022 at 10 am
Weightage of Investment (Rs.10 Lakh) | ||
Company | Amount (Rs) | Weightage (%) |
Asian Paints | 80,000 | 8% |
Infosys | 90,000 | 9% |
ITC | 70,000 | 7% |
LTIMindtree | 1,00,000 | 10% |
Maruti Suzuki | 90,000 | 9% |
Piramal Pharma | 1,00,000 | 10% |
Redington | 70,000 | 7% |
SBI | 90,000 | 9% |
Tata Chemicals | 1,00,000 | 10% |
Tata Steel | 1,20,000 | 12% |
Ultratech Cements | 90,000 | 9% |
Total | 10,00,000 | 100% |
Asian Paints Ltd.:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
3156 | ASIANPAINT/500820 | 3,01,486 | Paints/Varnishes | 95.92 | 1.00 | 147.03 | 0.80 |
Asian Paints Ltd. is the leading company in the paints sector in India with 80 years’ experience with presence in 15 countries across the world. The company manufactures a range of decorative and industrial paints. It also offers wall coverings, water proofing, adhesives and other services under its product portfolio. Company has started new range of hand, Surface and space sanitizers and disinfectants and also recently launched range of Furniture, Furnishings and Lighting Products under ‘Home Décor’ category. It is continuously showing double digit volume growth in Decorative Business in India from Q1FY22 to Q2FY23. Company has shown around 20% growth in the revenue from past 20 yrs. Asian Paints continues to grow because of its purchasing power; in spite of new entrants in the market, it still has over 50% market share in the Domestic Paints industry. Operating profit margin of the company would improve in the further quarters due to the decrease of raw materials price and ease in inflation.
Infosys Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
1643 | INFY/ 500209 | 6,89,515 | IT-Software | 2104.04 | 5.00 | 170.26 | 1.05 |
Infosys Ltd. is engaged to provide consulting, technology, outsourcing and next-generation digital services, to enable clients to execute strategies for their digital transformation. Its key services include application development, product co-development and system implementation/system engineering. The company shown growth across verticals; Sequential currency growth stood at 4% and large deals remain strong at $2.7 billion in the September quarter, growth of 28% YoY. Net Profit of Infosys grew 12.3% QoQ and Ebit margin grew by 150 bps QoQ at 21.5% for the same quarter. The company has increased revenue guidance to 15-16% from 14-16% for FY23.
ITC Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
336 | ITC/500875 | 4,18,290 | Cigarettes | 1241.03 | 1.00 | 52.88 | 0.62 |
ITC Ltd. is one of India’s foremost multi-business enterprise with diversified portfolio of businesses spanning in FMCG, Paperboards & Packaging, Agri Business, Hotels and Information Technology. It has been the top player in the cigarettes market and one of the leading FMCG brand in India. The company delivered robust performance across all segments in the September 2022 quarter. Revenue of the company increased 25% to Rs 16,930 crore in the Q2FY23 and Net profit also rose to 24.4% (YoY) to Rs 4,620 crore in the quarter ended September, 2022. The company’s cigarette business grew by 23.3% to Rs 6954 crore during the quarter, while FMCG-others business, which includes packaged food and personal care products, grew 21% to Rs 4,885 crore; the segment’s EBITDA Sustained at 9.5%. ITC reported a healthy performance across segments. The Cigarettes business is gaining market share and is going to maintain volumes because of stable tax policies. Also foreign portfolio investors have been increasing their positions in ITC for the last four consequent quarters.
LTI Mindtree Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
4975 | LTIM | 540005 | 1,47,129 | IT-Software | 29.58 | 1.00 | 311.19 | 1.19 |
LTI Mindtree Ltd. has become the fifth largest IT services company by market capitalization after the merger of Larsen & Toubro InfoTech Ltd. and Mindtree Ltd. The Company offers extensive range of IT services like application development, maintenance and outsourcing, enterprise solutions, infrastructure management services, testing, digital solutions and platform-based solutions to the clients in diverse industries. Total number of clients of the company are over 750 and its Key partners includes Adobe, AWS, Cisco, Google, Microsoft, IBM and Oracle. The combined entity offers high growth potential in the BFSI, Hi-tech and Retail segment and better margin due to increased operational efficiency. The combined entity has Revenue of more than Rs.15,000 Cr in H1. Management of the company is confident enough to chase larger deals in further quarters and has also improved the guidance for FY23.
Maruti Suzuki Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
8797 | MARUTI/ 532500 | 2,66,287 | Automobile | 151.04 | 5.00 | 1892.91 | 0.89 |
Maruti Suzuki India Ltd. is a subsidiary of Suzuki Motor Corporation, Japan. It is India’s top automobile manufacturer in the country with market share of 42% in the passenger car market. The principal activities of the Company are manufacturing, purchase and sale of motor vehicles, components and spare parts. The other activities of the Company comprise facilitation of pre-owned car sales, fleet management and car financing. The company delivered significant financial performance in the September quarter due to ease in semiconductor shortages and decline in commodity prices. Total revenue of the company rose to 28,546 crore up 48% YoY and Net profit also increase hugely by 334% to 2,113 crore for Q2FY23. In November 2022, total sales of the company increased by 14% yearly but exports declined by 7.7% YoY due to world economy slowdown. Maruti’s plan to launch more vehicles in the CNG variant and focus on the SUVs would further drive the growth in the coming period.
Piramal Pharma Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
142 | PPLPHARMA/543635 | 16,802 | Pharmaceuticals | 1193.32 | 10.00 | 56.18 | -0.04 |
Piramal Pharma Ltd. (PPL) is a pharmaceuticals company of the well-known Piramal Group. The Company manufactures and develops a wide range of pharmaceutical solutions through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. Business segments of the company includes Contract Development and Manufacturing Organization (CDMO), Complex hospitals generics, India Consumer healthcare and Ophthalmology. Some of the brands of the company in consumer healthcare includes Saridon, Lacto Calamine, Polycrol and Tetmosol. The company showed the Revenue of Rs.1720 Cr., up 9% in September quarter of FY23. Post covid the demand of their CDMO Services has gone up globally due to the China plus one strategy. In the complex hospitals generics segment, PPL gets advantage of less competitors from other Indian Pharma players. Management of the company remains positive for its future performance and expects 20% EBITDA margin in the next 3-5 years.
Redington India Ltd.:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
180 | REDINGTON/532805 | 13,906 | Trading | 156.30 | 2.00 | 79.60 | 0.97 |
Redington India Ltd. is a leading supply chain solutions provider in the world providing solutions to all categories of Information Technology, Telecom, Cloud, Lifestyle and Solar segment. The key business verticals of the company are Distribution, Services, Logistics Services and Emerging Businesses. It is a completely professionally managed company with no promoters and has expansive network of over 290+ brands association and 43,000+ channel partners and is serving to 38 emerging markets. The company has shown strong financial performance over the years with Revenue CAGR of 6.8% and PAT CAGR of 35.1% from FY20 to FY22. The company is expanding into new emerging geographies and also diversifying into solar and cloud service business. Redington is also enhancing presence in the logistics business in India and the Gulf which will further support the growth of the company.
State Bank of India Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
617 | SBIN/500112 | 5,42,215 | Banks | 892.46 | 1.00 | 347.07 | 1.06 |
State Bank of India Ltd. is India’s largest public sector bank operating from the last 40+ years with an extensive network of more than 21,000 branches, 55,000 ATMs in India and 232 international offices across 32 countries. It is a banking and financial services statutory body engaged in providing a wide range of products and services to individuals, commercial enterprises, large corporates, public bodies, and institutional customers. SBI has shown robust performance in the September quarter results. Consolidated revenue of the bank rose 15.7% YoY to Rs.84,463 Cr crore compared to 73,029 crore in the previous year same quarter while Net Profit of the bank increased hugely by 66% YoY at Rs.14,752 Cr. Assset quality of the bank has improved in Q2FY23 with GNPA ratio of 3.52% down by 39 bps QoQ and Net NPA of 0.8% compared to 1% in June quarter. Healthy loan growth momentum of the bank is expected to sustain led by retail and corporate loan growth.
Tata Chemicals Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
1057 | TATACHEM/500770 | 26,479 | Chemicals | 254.8 | 10.00 | 753.29 | 1.08 |
Tata Chemicals Ltd. is one of the largest manufacturer of soda ash and sodium bicarbonate for diverse industries, such as glass, detergents, silicates, textiles, food, pharmaceuticals, animal feed, mining and chemical processing. The September quarter result of the company showed significant growth. It reported 40% increase in its consolidated net sales for the quarter ended September 2022 to Rs 4,239 crore compared to corresponding previous year period because of robust soda ash demand. Net profit of the company was up 184% to Rs 629 crore YoY; Specialty products sales grew 27% YoY for the same quarter. Tata Chemicals continues to perform financially well despite of challenging global environment. Ongoing global shortage for soda ash shortage globally will further improve realisations through heightened pricing.
Tata Steel Ltd.:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
116 | TATASTEEL/500470 | 1,36,847 | Steel | 1221.3 | 1.00 | 87.29 | 1.15 |
Tata Steel Ltd. is one of the world’s largest steel companies with a global annual crude steel production capacity of 34 million tonnes per annum (MnTPA). The company has manufacturing units in 26 countries across globe and has presence in 50 countries. It has a strong portfolio of 11 retail brands. Tata Steel didn’t show good numbers in the September quarter due to moderate realization and high energy prices especially in Europe. However, recent decrease in coking coal prices and rise in infrastructure activity would continue to drive the demand in India. Company had recently announced the merger with 7 of its group companies which will benefit the company in increased operational efficiency, better facility utilization, working capital efficiency, better cash flow management, Scalability and Enhanced logistics over the long term.
Ultratech Cement Ltd:
CMP | NSE/BSE Symbol | MCAP (Cr) | Sector | Equity (Cr) | Face Value | Book Value | Beta-Sensex |
7190 | ULTRACEMCO/532538 | 2,08,938 | Cement | 288.7 | 10.00 | 1783.5 | 0.95 |
Ultratech Cement Limited is the leading cement company of the country which comes under the Aditya Birla Group. The company is engaged in the manufacture and sale of cement and cement related products. It is the largest cement manufacturer of grey cement, ready mix concrete and white cement in India with consolidated capacity of grey cement of 121.25 million tonnes per annum. On consolidated front, Ultratech reported 15.6% yearly growth in the Net Revenue to Rs.13,893 Cr while Net Profit decreased by 42% because of rising power & fuel cost and logistics cost, stood at Rs.759 Cr for the quarter ended September 2022. The company has announced robust expansion plan of 22.6 million tonnes per annum and expects capacity of 153.85 mtpa by FY25; post which expansion is planned to take capacity to ~200mtpa by FY30. Input cost for the cement companies have decreased recently which will further improve margin of the company.
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL